PepGel chosen one of the 20 most promising biotech providers
PepGel LLC today announced that CIO Review (www.cioreview.com) has chosen PepGel for its “20 Most Promising Biotechnology Solution Providers”. This recognition is based on evaluation of PepGel’s capabilities in providing a transformational new method for 3D Cell Culture. The annual list of companies is selected by a distinguished panel of CEOs, CIOs, VCs and analysts, and members of CIO Review’s editorial board, to acknowledge and promote entrepreneurship in biotechnology.
“While PepGel is a young company, it appeared quickly on our radar as a company to watch, given their breakthrough new hydrogel technology,” said Harvi Sachar, publisher and founder, CIO Review.
“PepGel is honored to be recognized by CIO Review’s panel of experts and thought leaders as a top biotech solution provider,” said Xiuzhi Susan Sun, president and co-founder of PepGel. “This recognition is a reflection of our ongoing commitment to deliver meaningful new solutions to our clients and success in creating exceptional customer experiences.”